Stock ASPI ASP ISOTOPES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ASP Isotopes Inc.

Equities

ASPI

US00218A1051

End-of-day quote Nasdaq
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
5.11 USD -5.89% Intraday chart for ASP Isotopes Inc. -5.89% +185.47%
15/05 ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
10/04 ASP Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ASP Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Power Producers Gain as Defensive Play -- Utilities Roundup
DJ
ASP Isotopes Inc. Enters into A Contract with U.S.-Based Small Modular Reactor for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels
CI
ASP Isotopes Inc. Enters into Purchase Agreement with A Leading Semiconductor Company for the Supply of Highly Enriched Electronic Gases
CI
ASP Isotopes Inc. agreed to Spin-Off Quantum Leap Energy LLC.
CI
ASP Isotopes Inc. Commences Construction of Its Third Isotopes in South Africa
CI
Asp Isotopes Inc. Enters into Memorandum of Understanding with Second Us-Based Small Modular Reactor Company to Supply High Assay Low Enriched Uranium
CI
ASP Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
ASP Isotopes Inc. acquired 51% stake in Pet Labs Pharmaceuticals Proprietary Limited from Nucleonics Imaging Proprietary Limited for $2 million.
CI
ASP Isotopes Inc. agreed to acquire 51% stake in Pet Labs Pharmaceuticals Proprietary Limited from Nucleonics Imaging Proprietary Limited for $2 million.
CI
ASP Isotopes Inc. Enters into Memorandum of Understanding with A Small Modular Reactor Company to Supply High Assay Low Enriched Uranium
CI
ASP Isotopes Inc. Receives A Prepayment of Approximately $900,000 from A Customer
CI
ASP Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
ASP Isotopes Inc. Secures $9 Million Supply Contract with US Customer for Highly Enriched Isotopes
CI
ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ASP Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
ASP Isotopes Set for Commercial Launch with Completion of First Isotopes Enrichment Facility
CI
ASP Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
ASP Isotopes Inc. Enters into 25-Year Supply Agreement Valued At Up to $27 Million Per Annum for Highly Enriched Molybdenum-100
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASPI Stock
  4. News ASP Isotopes Inc.
  5. Highlights